Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-009450

Chief Accounting Officer sold 25,000 shares at $25.21 ($630,320)

  • Chief Accounting Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lyon Joseph Douglas Chief Accounting Officer 2021-03-01 Option exercise +25,000 $8.27 $206,750 25,000 D: show line 1 in the form
Lyon Joseph Douglas Chief Accounting Officer 2021-03-01 Sale −25,000 $25.21 $630,320 0 D: show line 2 in the form
Open-market sales · 25,000 sh · avg $25.21 · $630,320

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lyon Joseph Douglas Chief Accounting Officer 2021-03-01 Option exercise · Stock Option (Right to Buy) −25,000 4,167 D: show line 3 in the form
Loading xslF345X03/doc4.xml…